Galectin Therapeutics Inc SEC filings GALT

Galectin Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Oct 18, 2011. Its latest annual report, Form ARS, was filed on Oct 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Galectin Therapeutics Inc SEC filings
Form Description Filed Period
ARS Annual report to shareholders Oct 13, 2026 Dec 31, 2025
DEFA14A Additional proxy material Oct 13, 2026 —
DEF 14A Proxy statement Oct 13, 2026 Dec 3, 2026
PRE 14A Preliminary proxy statement Oct 2, 2026 Dec 3, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 4, 2026 —
4 Insider transaction Aug 4, 2026 Jul 31, 2026
8-K Current report
Unregistered share sale
Aug 4, 2026 Jul 31, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 25, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 23, 2026 —
8-K Current report
Regulation FD disclosure
Jun 23, 2026 Jun 23, 2026
4 Insider transaction May 28, 2026 May 26, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
EFFECT Filing Apr 10, 2026 —
CORRESP Letter to the SEC Apr 8, 2026 —
UPLOAD Letter from the SEC Apr 6, 2026 —
S-3 Shelf registration Mar 31, 2026 —
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
4 Insider transaction Mar 17, 2026 Mar 12, 2026
3 Initial insider ownership Mar 17, 2026 Mar 12, 2026
8-K Current report
Officer or director change
Mar 17, 2026 Mar 12, 2026
4 Insider transaction Feb 9, 2026 Feb 6, 2026
4/A Form 4/a Jan 22, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
8-K Current report
Officer or director change
Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 13, 2026 Jan 5, 2026
8-K Current report
Officer or director change
Jan 12, 2026 Jan 10, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 6, 2026 —
144/A Filing Jan 5, 2026 —
4 Insider transaction Jan 5, 2026 Dec 31, 2025
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Dec 31, 2025 —
4/A Form 4/a Dec 23, 2025 Dec 23, 2025
4/A Form 4/a Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
8-K Current report
Material agreement
Dec 19, 2025 Dec 19, 2025
4 Insider transaction Dec 18, 2025 Nov 24, 2025
144 Notice of proposed sale Dec 17, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144/A Filing Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 9, 2025 —
144 Notice of proposed sale Dec 8, 2025 —
4/A Filing Dec 8, 2025 Dec 2, 2025
8-K Current report
Shareholder vote results
Dec 8, 2025 Dec 3, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
8-K Current report
Regulation FD disclosure
Dec 3, 2025 Dec 3, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
144 Notice of proposed sale Nov 13, 2025 —
4 Insider transaction Nov 12, 2025 Oct 22, 2025
4 Insider transaction Nov 12, 2025 Nov 10, 2025
4 Insider transaction Nov 12, 2025 Nov 10, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
ARS Annual report to shareholders Oct 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Oct 22, 2025 —
DEF 14A Proxy statement Oct 22, 2025 Dec 3, 2025
5 Annual insider ownership Oct 10, 2025 Dec 31, 2024
4 Insider transaction Sep 15, 2025 Sep 12, 2025
4 Insider transaction Sep 15, 2025 Sep 12, 2025
144 Notice of proposed sale Sep 12, 2025 —
144 Notice of proposed sale Sep 12, 2025 —
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
4 Insider transaction Jul 22, 2025 Jul 21, 2025
4 Insider transaction Jul 18, 2025 Jul 17, 2025
8-K Current report
Material agreement, Officer or director change
Jul 9, 2025 Jul 8, 2025
8-K Current report
Regulation FD disclosure
Jun 16, 2025 Jun 16, 2025
4 Insider transaction Jun 11, 2025 Feb 3, 2025
5 Annual insider ownership Jun 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure, Other events
May 12, 2025 May 12, 2025
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
4 Insider transaction Mar 5, 2025 Mar 3, 2025
8-K Current report
Regulation FD disclosure
Mar 5, 2025 Mar 5, 2025
8-K Current report
Other events
Feb 18, 2025 Feb 18, 2025
4 Insider transaction Jan 30, 2025 Jan 23, 2025
8-K Current report
Shareholder vote results
Jan 28, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
8-K Current report
Regulation FD disclosure
Jan 23, 2025 Jan 23, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Dec 31, 2024 Dec 30, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 24, 2024
4 Insider transaction Dec 26, 2024 Dec 24, 2024
4 Insider transaction Dec 26, 2024 Dec 24, 2024
144 Notice of proposed sale Dec 23, 2024 —
144 Notice of proposed sale Dec 23, 2024 —
144 Notice of proposed sale Dec 23, 2024 —
8-K Current report
Other events
Dec 20, 2024 Dec 20, 2024
ARS Annual report to shareholders Dec 3, 2024 Dec 31, 2023
DEFA14A Additional proxy material Dec 3, 2024 —
DEF 14A Proxy statement Dec 3, 2024 Jan 23, 2025
8-K Current report
Regulation FD disclosure
Nov 14, 2024 Nov 14, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
4 Insider transaction Oct 23, 2024 Oct 23, 2024
4 Insider transaction Oct 17, 2024 Oct 17, 2024
4 Insider transaction Oct 16, 2024 Oct 16, 2024
144 Notice of proposed sale Oct 4, 2024 —
8-K Current report
Regulation FD disclosure
Sep 9, 2024 Sep 9, 2024
4 Insider transaction Aug 26, 2024 Aug 22, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
3 Initial insider ownership Aug 5, 2024 Aug 2, 2024
8-K Current report
Officer or director change
Aug 1, 2024 Jul 26, 2024
4/A Filing Jul 23, 2024 Jul 22, 2024
4 Insider transaction Jul 23, 2024 Jul 22, 2024
4 Insider transaction Jun 20, 2024 Jun 20, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
4 Insider transaction Apr 30, 2024 Apr 30, 2024
4 Insider transaction Apr 25, 2024 Apr 24, 2024
5 Annual insider ownership Apr 25, 2024 Dec 31, 2023
4 Insider transaction Apr 25, 2024 Apr 22, 2024
4 Insider transaction Apr 22, 2024 Apr 22, 2024
4 Insider transaction Apr 9, 2024 Apr 9, 2024
8-K Current report
Results of operations
Mar 29, 2024 Mar 29, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
4 Insider transaction Mar 4, 2024 Mar 1, 2024
3 Initial insider ownership Feb 16, 2024 Dec 7, 2023
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Jan 16, 2024 Jan 16, 2024
4 Insider transaction Jan 2, 2024 Dec 29, 2023
4 Insider transaction Dec 18, 2023 Dec 15, 2023
8-K Current report
Shareholder vote results
Dec 11, 2023 Dec 7, 2023
8-K Current report
Regulation FD disclosure
Dec 7, 2023 Dec 7, 2023
5 Annual insider ownership Dec 1, 2023 Jan 12, 2022
SC 13D/A Amended ownership over 5% (active) Dec 1, 2023 —
4 Insider transaction Dec 1, 2023 Nov 30, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GALT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Norcross, GA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1133416
Former names
PRO PHARMACEUTICALS INC (until May 26, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.